373
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Therapeutic potential of new second generation antipsychotics for major depressive disorder

, MD, , PhD, , CNP & , MD
Pages 1527-1544 | Published online: 25 Nov 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Changsu Han, Sheng-Min Wang, Masaki Kato, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand & Chi-Un Pae. (2013) Second-generation antipsychotics in the treatment of major depressive disorder: current evidence. Expert Review of Neurotherapeutics 13:7, pages 851-870.
Read now
Michele Fornaro, Eugenio Aguglia, Liliana Dell'Osso & Giulio Perugi. (2011) Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs?. Expert Opinion on Pharmacotherapy 12:18, pages 2817-2831.
Read now
Andrea Fagiolini, Maria Nitti, Rocco N Forgione, Francesco S Marra & Francesco Casamassima. (2011) Aripiprazole for the treatment of bipolar disorder: a review of current evidence. Expert Opinion on Pharmacotherapy 12:3, pages 473-488.
Read now

Articles from other publishers (8)

Omid Ameli, Rene Soria-Saucedo, Eric G. Smith, Howard J. Cabral, Marina Soley-Bori & Lewis E. Kazis. (2017) Associations Between Medication Class and Subsequent Augmentation of Depression Treatment in Privately Insured US Adults. Journal of Clinical Psychopharmacology 37:3, pages 323-331.
Crossref
Sofian Berrouiguet, Maria Luisa Barrigón, Sara A. Brandt, Santiago Ovejero-García, Raquel Álvarez-García, Juan Jose Carballo, Philippe Lenca, Philippe Courtet & Enrique Baca-García. (2016) Development of a Web-Based Clinical Decision Support System for Drug Prescription: Non-Interventional Naturalistic Description of the Antipsychotic Prescription Patterns in 4345 Outpatients and Future Applications. PLOS ONE 11:10, pages e0163796.
Crossref
Olivier Doumy, Djamila Bennabi, Wissam El-Hage, Najib Allaïli, Rémy Bation, Frank Bellivier, Jérôme Holtzmann, Maxime Bubrovszky, Vincent Camus, Thomas Charpeaud, Pierre Courvoisier, Thierry d’Amato, Marion Garnier, Frédéric Haesebaert, Thierry Bougerol, Christophe Lançon, Fanny Moliere, Isabel Nieto, Raphaëlle Richieri, Ghassen Saba, Philippe Courtet, Guillaume Vaiva, Marion Leboyer, Pierre-Michel Llorca, Bruno Aouizerate & Emmanuel Haffen. (2016) Dépression résistante : les stratégies de potentialisation. La Presse Médicale 45:3, pages 338-349.
Crossref
Yu-Xi Wang, Yu-Tao Xiang, Yun-Ai Su, Qian Li, Liang Shu, Chee H Ng, Gabor S Ungvari, Helen FK Chiu, Yu-Ping Nin, Gao-Hua Wang, Pei-Shen Bai, Tao Li, Li-Zhong Sun, Jian-Guo Shi, Xian-Sheng Chen, Qi-Yi Mei, Ke-Qing Li, Xin Yu & Tian-Mei Si. (2015) Antipsychotic Medications in Major Depression and the Association with Treatment Satisfaction and Quality of Life. Chinese Medical Journal 128:14, pages 1847-1852.
Crossref
J. Craig Nelson, Zia Rahman, Kimberly K. Laubmeier, James M. Eudicone, Robert D. McQuade, Robert M. Berman, Ronald N. Marcus, Ross A. Baker & John J. Sheehan. (2014) Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy. CNS Spectrums 19:6, pages 528-534.
Crossref
Alessia Luoni, Sjoerd Hulsken, Greta Cazzaniga, Giorgio Racagni, Judith R. Homberg & Marco A. Riva. (2013) Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats. International Journal of Neuropsychopharmacology 16:6, pages 1319-1330.
Crossref
Ayaka Tatara, Saki Shimizu, Noriyuki Shin, Maho Sato, Tomone Sugiuchi, Junta Imaki & Yukihiro Ohno. (2012) Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 38:2, pages 252-259.
Crossref
Olga Chernoloz, Mostafa El Mansari & Pierre Blier. (2012) Effects of Sustained Administration of Quetiapine Alone and in Combination with a Serotonin Reuptake Inhibitor on Norepinephrine and Serotonin Transmission. Neuropsychopharmacology 37:7, pages 1717-1728.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.